AP NEWS

SpineVision® Receives FDA Clearance and CE Mark for Next-Gen Titanium 3D-Printed HEXANIUM TLIF Cage

September 17, 2018

ANTONY, France--(BUSINESS WIRE)--Sep 17, 2018--SpineVision announced today that it has received FDA clearance and CE mark for its next-generation titanium 3D laser-printed HEXANIUM TLIF (Transforaminal Lumbar Interbody Fusion) cage for back surgery. SpineVision will introduce its new product to spine surgeons at “EuroSpine 2018” (Booth #24C) in Barcelona, Spain (Sept. 19-21), and “NASS 2018” (Booth #1311) in Los Angeles (Sept. 26-29).

Spine fusion surgery is often necessary to stop the motion of a painful segment in the spine by fusing two vertebrae with a TLIF cage. Conditions that may be treated with a spine fusion include tumors, spinal stenosis, herniated discs, and degenerative disc disease. The HEXANIUM TLIF cage combines a roughened titanium surface designed for fast osseointegration along with a honeycomb-like structure that features large windows for maximizing bone in-growth and on-growth from endplate to endplate.

“While TLIF back surgery is successful at relieving patients’ pain in about 60 to 70 percent of cases, there is room for improvement,” said Arnaud Brisard, CEO of SpineVision. “In particular, our HEXANIUM TLIF cage is designed to reduce the risk of subsidence in disc height in the post-operative period. HEXANIUM represents a continuation of our substantial achievements in developing cutting-edge products for all spine pathologies. HEXANIUM TLIF is the first of a complete range of 3D-printed implants SpineVision will be introducing.”

“Hexanium TLIF is an advance for spine fusion surgery,” said NeurosurgeonGary P. Colon, M.D., NCH Healthcare System, Naples, Fla. “I am able now to deploy the TLIF cage exactly where my intent is when I start the approach. And that’s been a big move forward compared to prior products that I used.”

View source version on businesswire.com:https://www.businesswire.com/news/home/20180917005062/en/

CONTACT: Ronald Trahan Associates Inc.

Ronald Trahan, APR, +1 508-816-6730

rtrahan@ronaldtrahan.com

KEYWORD: UNITED STATES EUROPE NORTH AMERICA FRANCE NEW YORK

INDUSTRY KEYWORD: SURGERY HEALTH MEDICAL DEVICES OTHER HEALTH FDA

SOURCE: SpineVision

Copyright Business Wire 2018.

PUB: 09/17/2018 07:00 AM/DISC: 09/17/2018 07:00 AM

http://www.businesswire.com/news/home/20180917005062/en

AP RADIO
Update hourly